Changing Outcomes

CHANGING LIVES!

Treating Stroke and Vascular Occlusions

Stroke and cardiovascular disease, the biggest global killers, account for close to a third of annual deaths worldwide. Vascular occlusions from heart attacks and strokes claim an estimated 30 lives every minute.

Vesalio innovates to improve care for patients with vascular occlusions. Through state-of-the-art technology, Vesalio empowers physicians with tools to elevate clinical outcomes and change lives.

SPOTLIGHT ON NEVA™
NEVA CLEAR RESULTS PUBLISHED

Primary results from the prospective, international, multicenter FDA IDE study CLEAR demonstrated impressive clinical outcomes with Vesalio’s NeVa™ thrombectomy device in treating acute ischemic stroke caused by large vessel occlusions.

Prof. Laurent Spelle (Paris, FRANCE), Prof. Raul Nogueira (Pittsburgh, U.S.), and Prof. Serdar Geyik (Istanbul, TURKEY) discuss the results of the CLEAR trial.

CLOT BURDEN:
A BROAD ANATOMICAL CONCERN

Neurovascular

Clots block circulation to an artery in the brain causing damage and loss of neurological function

AIS

Cardiovascular

Clots restrict blood flow to a major artery in the heart, causing a heart attack and muscle damage

STEMI

Peripheral Vascular

Clots can block flow anywhere in the body resulting in additional acute conditions such as

Pulmonary Embolisms

TAKING CLOT CAPTURE TO THE NEXT LEVEL
WITH
 DROP ZONETM TECHNOLOGY

Clots vary in density, size, and composition. Adding to the challenge, physicians cannot ascertain clot type before an intervention.

Vesalio’s Drop Zone™ Technology  with its ALL CLOTS CAPABILITY brings substantial advantages to physicians and patients in thrombectomy procedures.

Find out more:

Find out more:

Find out more:

A SPECIFIC SOLUTION
FOR POST A-SAH VASOSPASM

Vasospasm is a frequently occurring and dangerous complication of aneurysmal subarachnoid hemorrhage (a-SAH).

Vesalio’s NeVa VS is the first and only FDA HDE approved device for the adjunct treatment in this indication.

Find out more:

Do The Drop Zone

Would you like to know more?